Computerized Education for Kidney Disease
(ICCKD Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests a new computerized education program for African-American patients with advanced chronic kidney disease (CKD). It aims to determine if this program enhances patients' understanding of CKD management and treatment options more effectively than standard hospital information. The trial includes two groups: one receiving usual care with general health tips and another using the computerized education specifically about CKD. African-American patients in the hospital with certain kidney function levels, who are not currently on dialysis, might be suitable for this trial. As an unphased trial, this study offers a unique opportunity for patients to contribute to research that could improve CKD education and management.
Do I need to stop my current medications for this trial?
The trial information does not specify whether you need to stop taking your current medications.
What prior data suggests that this computerized education program is safe for patients with advanced chronic kidney disease?
Research has shown that computerized education programs for chronic kidney disease (CKD) have been well received in past studies. These programs aim to increase understanding of CKD and teach self-care, which is crucial for managing the condition. While specific information on side effects for this type of program is lacking, its educational and computer-based nature suggests a low risk of harm. Learning through a computer is generally considered safe for participants.12345
Why are researchers excited about this trial?
Researchers are excited about the Computerized CKD Education because it offers a personalized approach to educating patients about chronic kidney disease. Unlike standard care, which often involves general health information and printed materials, this computerized method adapts its content based on initial participant data, ensuring that each person receives information tailored to their specific needs and understanding. This innovative approach has the potential to enhance patient engagement and knowledge retention, leading to better management of kidney disease.
What evidence suggests that this computerized education is effective for increasing CKD knowledge and self-care intent?
Research has shown that computerized adaptive education (CAE), which participants in this trial may receive, can greatly enhance understanding of chronic kidney disease (CKD) and self-care practices. Studies have found CAE to be more effective than standard hospital care in educating and motivating patients to manage CKD. Early results suggest that this education boosts patients' readiness for self-care and consideration of future treatment options. This method is particularly beneficial for hospitalized African-American patients, as it offers education tailored to their specific needs.12346
Who Is on the Research Team?
Milda Saunders, MD
Principal Investigator
Associate Professor of Medicine
Are You a Good Fit for This Trial?
This trial is for hospitalized African-American patients with advanced chronic kidney disease (CKD), including those with high blood pressure. The study focuses on evaluating a computerized education program tailored to their cultural needs.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Intervention
Participants receive either usual care or computerized patient education, with baseline and post-intervention assessments
Follow-up
Participants are monitored for changes in CKD knowledge, health intent, and self-management behaviors
What Are the Treatments Tested in This Trial?
Interventions
- Computerized CKD Education
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Chicago
Lead Sponsor
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Collaborator